BIOMAT Database Logo BIOMAT Database Logo

Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy. 1990

T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
First Department of Internal Medicine, Mie University, Tsu, Japan.

We investigated the effects of nifedipine on left ventricular diastolic function in 17 asymptomatic or minimally symptomatic patients with hypertrophic cardiomyopathy by simultaneously measuring left ventricular pressure and volume with a catheter-tipped manometer and biplane cineangiography. Studies were performed before and 20 minutes after sublingual administration of nifedipine (20 mg). Heart rates were held constant (79 +/- 12 beats/min, mean +/- SD) by right atrial pacing. Left ventricular volumes and instantaneous rates of left ventricular volume were derived from frame-by-frame (20-msec) analyses of left ventricular biplane angiograms. Left ventricular peak systolic pressure (from 122 +/- 21 to 108 +/- 13 mm Hg, p less than 0.01 vs. control) and mean aortic pressure (from 96 +/- 15 to 87 +/- 11 mm Hg, p less than 0.01) decreased significantly with nifedipine. With afterload reduction, left ventricular ejection fraction (from 0.69 +/- 0.12 to 0.74 +/- 0.08, p less than 0.01) and cardiac output (from 6.4 +/- 2.0 to 7.2 +/- 2.2 l/mm, p less than 0.05) increased significantly. However, there was a slight but significant increase in left ventricular end-diastolic pressure (from 15 +/- 8 to 18 +/- 8 mm Hg, p less than 0.05). Nifedipine did not improve left ventricular relaxation as assessed by the time constants of isovolumic pressure decay (t1/2, from 39.8 +/- 6.6 to 39.4 +/- 7.7 msec, NS; t1/e, from 53.8 +/- 9.0 to 54.4 +/- 10.7 msec, NS).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008365 Manometry Measurement of the pressure or tension of liquids or gases with a manometer. Tonometry,Manometries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D002304 Cardiac Pacing, Artificial Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. Pacing, Cardiac, Artificial,Artificial Cardiac Pacing,Artificial Cardiac Pacings,Cardiac Pacings, Artificial,Pacing, Artificial Cardiac,Pacings, Artificial Cardiac
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D002932 Cineangiography Motion pictures of the passage of contrast medium through blood vessels. Cineangiographies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
[Left ventricular diastolic function in patients with hypertrophic cardiomyopathy].
January 1992, Terapevticheskii arkhiv,
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy.
August 1994, The American journal of cardiology,
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
Left ventricular diastolic function in hypertrophic cardiomyopathy.
February 1991, Herz,
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
[Effects of verapamil on the left ventricular diastolic function and diastolic asynchrony in patients with hypertrophic cardiomyopathy].
January 1991, Journal of cardiology,
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
Diastolic left ventricular function after nifedipine in healthy subjects and hypertrophic obstructive cardiomyopathy (CAPS) patients.
January 1988, Acta cardiologica,
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
Effects of nicorandil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy.
March 1995, Japanese circulation journal,
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.
March 1982, Circulation,
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
January 2006, Heart international,
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
Prognostic significance of right ventricular function during exercise in asymptomatic/minimally symptomatic patients with nonobstructive hypertrophic cardiomyopathy.
June 2021, Echocardiography (Mount Kisco, N.Y.),
T Yamakado, and H Okano, and S Higashiyama, and M Hamada, and T Nakano, and H Takezawa
[Left ventricular diastolic function in apical hypertrophic cardiomyopathy].
January 1992, Journal of cardiology,
Copied contents to your clipboard!